On Jan. 15, the state reported 5,490 new COVID-19 cases and 67 confirmed deaths, bringing those respective cumulative totals to 616,090 and 20,418.
On Jan. 13, the state reported 6,922 new COVID-19 cases and 95 confirmed deaths, bringing those respective cumulative totals to 602,629 and 20,167.
As a new year is rung in, there are a spate of new laws that are going into effect.
For the time period between Dec. 24 through Dec. 27, New Jersey tallied 16,320 new COVID-19 cases and 170 confirmed deaths.
The state this week set up resources for those frontline healthcare workers who are struggling with their mental health.
The state will have six mega sites throughout New Jersey to serve as vaccination hubs for phased priority groups.
The law would allow new drivers who passed their road tests to drive for 60 days while waiting to receive their probationary drivers’ license.
For the weekend of Dec. 12 and 13, the cumulative number of coronavirus cases in New Jersey reached 400,650 with 10,417 total new cases reported and 95 new deaths, bringing that total to 15,883.
New Jersey officials in the last 10 days have offered insight on how and when the COVID-19 vaccine will be distributed throughout the Garden State.
State officials rolled out New Jersey’s COVID-19 vaccination plan when one becomes available.
State officials rolled out the state’s COVID-19 vaccination plan when one becomes available, designed to provide equitable access, achieve maximum community protection and build public trust in advance of an approved vaccine.
Gov. Phil Murphy said President Donald Trump’s decision to attend a fundraiser in New Jersey showed “a lack of leadership and not for the first time” in dealing with the COVID-19 crisis.
Two bills to address issues arising from the COVID-19 crisis at long-term care facilities sponsored by Assemblywoman Valerie Vainieri Huttle were recently approved by both houses and now await action by Gov. Phil Murphy.
Concerns about the availability of COVID-19 testing supplies and personal protective equipment (PPE) have spurred action from the Senate, while a fifth-district manufacturer creating a partnership with the federal government to prepare for the development of a vaccine.